The business experienced significant growth over the past year, achieving a profit of £2240 with minimal advertising expenditure. The products are essential for institutional buyers, fostering repeat business. The business boasts a 95% acquisition of the buy box, indicating a competitive edge in the market. There are dormant SKUs that are profitable and awaiting replenishment. The operational focus is primarily on maintaining stock levels, as some SKUs experience extremely high demand and are often sold in multiples. Suppliers are available through major online marketplaces, with the necessary contact details provided. The products in focus are healthcare-related and face no selling restrictions. The customer base is diverse, including private hospitals, care homes, and schools. There is potential for a price increase, with current pricing reportedly below market value. Customers tend to return regularly, with some purchasing monthly. While the business had a slow start, experiencing challenges in direction during the first half of the year, it began to grow rapidly from January. Stock sourced from China started contributing significantly to this growth. Currently, the business struggles to keep up with demand due to cash constraints, preventing it from capitalizing on highly profitable dormant SKUs. Despite low returns stemming from reliable suppliers, the business is positioned as a ready-to-go venture that requires additional capital for expansion. The model is established with a loyal institutional customer base, selling non-seasonal products year-round, fulfilling essential healthcare compliance requirements for institutions. There is a strategic blueprint available for developing further SKUs for interested buyers.